Literature DB >> 56982

Mesenchymal tumors of the uterus. VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear-cell leiomyoma: a clinical and pathologic analysis of 26 cases.

R J Kurman, H J Norris.   

Abstract

Twenty-six cases of atypical smooth muscle tumors of the uterus, including leiomyoblastoma, epithelioid leiomyoma, clear-cell leiomyoma, and plexiform tumorlet, are presented. The characteristic microscopic feature serving as the basis for inclusion in this study is the rounded to polygonal shape of the majority of cells instead of the elongated blunt-ended shape of smooth muscle cells seen in the typical leiomyoma. Mixtures of epithelioid, clear-cell, and plexiform patterns occurred with sufficient frequency to indicate that such patterns are variants of a single entity. A transition to typical smooth muscle cells was found in most instances, confirming the smooth muscle origin of these tumors. Features related to a favorable prognosis include the presence of clear cells, an expansile tumor margin, extensive hyalinization, and absence of extensive necrosis as seen microscopically. Until additional evidence has been accumulated it is proposed that neoplasms having five or more mitotic figures per ten high-power fields (HPF) be tentatively termed epithelioid leiomyosarcoma or leiomyosarcoma with epithelioid features and those with less than five mitotic figures per ten HPF, epithelioid leiomyoma.

Entities:  

Mesh:

Year:  1976        PMID: 56982     DOI: 10.1002/1097-0142(197604)37:4<1853::aid-cncr2820370433>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Epithelioid leiomyosarcoma of uterus.

Authors:  Aparna Setia; Shalini Kanotra; Ritika Aggarwal; Dilip Prabhakarrao Bhavthankar
Journal:  BMJ Case Rep       Date:  2012-04-02

2.  Leiomyoblastoma of the omentum.

Authors:  D Lalji; W Morris; B Bose
Journal:  Can Med Assoc J       Date:  1980-03-22       Impact factor: 8.262

Review 3.  Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia.

Authors:  Esther Oliva
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

4.  PGR Gene Fusions Identify a Molecular Subset of Uterine Epithelioid Leiomyosarcoma With Rhabdoid Features.

Authors:  Sarah Chiang; Wesley Samore; Lei Zhang; Yun-Shao Sung; Gulisa Turashvili; Rajmohan Murali; Robert A Soslow; Martee L Hensley; David Swanson; Brendan C Dickson; Colin J R Stewart; Esther Oliva; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2019-06       Impact factor: 6.394

5.  [Recurring clear cell leiomyoblastoma of the uterus (author's transl)].

Authors:  G Dallenbach-Hellweg; H Epple; P Birovljev; H Fischbach
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-09-21

6.  [Mesenchymal uterine tumors. Leiomyomas].

Authors:  S Lax
Journal:  Pathologe       Date:  2009-07       Impact factor: 1.011

7.  Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors.

Authors:  Bernadette Liegl-Atzwanger; Ellen Heitzer; Karin Flicker; Stephanie Müller; Peter Ulz; Ozlen Saglam; Fattaneh Tavassoli; Mojgan Devouassoux-Shisheboran; Jochen Geigl; Farid Moinfar
Journal:  Mod Pathol       Date:  2016-07-01       Impact factor: 7.842

8.  Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids.

Authors:  Jennelle C Hodge; Bradley J Quade; Mark A Rubin; Elizabeth A Stewart; Paola Dal Cin; Cynthia C Morton
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

9.  Epithelioid haemangioendothelioma of the bone tissue.

Authors:  N Maruyama; Y Kumagai; Y Ishida; H Sato; I Sugano; K Nagao; Y Kondo
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

10.  Rodent model of reproductive tract leiomyomata. Clinical and pathological features.

Authors:  J I Everitt; D C Wolf; S R Howe; T L Goldsworthy; C Walker
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.